Pleomorphic Rhabdomyosarcoma
8 clinical trials · Condition
◉ Watch Pleomorphic Rhabdomyosarcoma
| Record | Firm | Date |
|---|---|---|
| Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma (NCT04420975) | Jonsson Comprehensive Cancer Center | 2020-10-14 |
| Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas (NCT03989596) | Maria Sklodowska-Curie National Research Institute of Oncology | 2018-06-01 |
| Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery (NCT03009201) | OHSU Knight Cancer Institute | 2017-03-10 |
| Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall (NCT03651375) | Maria Sklodowska-Curie National Research Institute of Oncology | 2017-02-11 |
| Sorafenib Tosylate, Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With High-Risk Stage IIB-IV Soft Tissue Sarcoma (NCT02050919) | OHSU Knight Cancer Institute | 2013-12-03 |
Track Pleomorphic Rhabdomyosarcoma automatically
Every clearance here is in the API, with alerts when new ones post.